Orthocell Secures Approval to sell Remplir™ to the U.S. Department of Defence Hospital Network [TheStreet.com]
Henry Schein, Inc. (HSIC)
Last henry schein, inc. earnings: 2/20 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=74322&p=irol-irhome
Company Research
Source: TheStreet.com
PERTH, Australia April 16, 2026 /PRNewswire/ -- Regenerative medicine company Orthocell Limited (ASX: OCC, "Orthocell" or the "Company") is pleased to announce it has secured approval for its Remplir™ nerve repair device to be used across the United States Department of Defence (DoD) and Veterans Affairs (VA) hospital networks. This approval provides access to approximately 51 DoD military hospitals and 170 VA medical centres across the United States, representing a significant milestone in expanding Orthocell's access to the U.S. market. Orthocell's established U.S. distributor network, which currently covers 17 states, will now target military and VA surgeons operating within these hospital systems. A significant portion of these facilities could be serviced by the Company's existing distribution footprint, supporting efficient market penetration. This expansion into the defence setting follows the recent clinical use of Remplir in 23 surgical procedures on injured soldiers i
Show less
Read more
Impact Snapshot
Event Time:
HSIC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HSIC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HSIC alerts
High impacting Henry Schein, Inc. news events
Weekly update
A roundup of the hottest topics
HSIC
News
- Henry Schein (HSIC) was upgraded by Citigroup Inc. to "strong-buy".MarketBeat
- Henry Schein (HSIC) is now covered by BTIG Research. They set a "neutral" rating on the stock.MarketBeat
- Henry Schein (HSIC) is now covered by Citigroup Inc.. They set a "buy" rating on the stock.MarketBeat
- How Investors Are Reacting To Henry Schein (HSIC) Board Overhaul After Bergman's Retirement [Yahoo! Finance]Yahoo! Finance
- A Look At Henry Schein (HSIC) Valuation As Board Overhaul Reshapes Governance [Yahoo! Finance]Yahoo! Finance
HSIC
Earnings
- 2/24/26 - Beat
HSIC
Sec Filings
- 4/8/26 - Form ARS
- 4/8/26 - Form DEFA14A
- 4/8/26 - Form DEF
- HSIC's page on the SEC website